A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and in Combination With Trametinib in Subjects With BRAF V600 Mutant Solid Tumors

A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and in Combination With Trametinib in Subjects With BRAF V600 Mutant Solid Tumors
United States, Massachusetts Dana-Farber Cancer Institute Not yet **RECRUITING NOW** Boston, Massachusetts, United States, 02215 United States, New York David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center Not yet **RECRUITING NOW** New York, New York, United States, 10021 United States, Tennessee Sarah Cannon and HCA Research Institute Not yet **RECRUITING NOW** Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Center Not yet **RECRUITING NOW** Houston, Texas, United States, 77030 United States, Virginia Virginia Cancer Specialists (NEXT Oncology Virginia) **RECRUITING NOW** Fairfax, Virginia, United States, 22031 France Institut Bergonie Not yet **RECRUITING NOW** Bordeaux Cedex, France, 33076 Spain NEXT Oncology Barcelona Not yet **RECRUITING NOW** Barcelona, Spain, 08023 Hospital Universitario Vall d’Hebron Not yet **RECRUITING NOW** Barcelona, Spain, 08035 South Texas Accelerated Research Therapeutics (START) Madrid – Hospital Fundacion Jiminez Diaz Not yet **RECRUITING NOW** Madrid, Spain, 28040 Hospital Clinico Universitario de Valencia Not yet **RECRUITING NOW** Valencia, Spain, 46010

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 31, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments